MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
CONMED Corporation Market Cap 2011-2026 | CNMD
As of March 06, 2026 CONMED Corporation has a market cap of $ 1.29 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.32 B | 1.94 B | 2.44 B | 2.85 B | 4.13 B | 3.18 B | 2.96 B | 1.94 B | 1.61 B | 1.21 B | 1.02 B | 1.31 B | 1.16 B | 829 M | 828 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.13 B | 828 M | 1.91 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 12.42 | -4.46 % | $ 1.86 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 38.55 | 0.13 % | $ 5.74 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 8.31 | 1.4 % | $ 597 M |  Israel |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 9.61 | -0.62 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
175 M | $ 24.26 | -0.12 % | $ 205 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 4.19 | -1.41 % | $ 156 M |  France |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 29.15 | -0.24 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.27 | -0.82 % | $ 113 M | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.59 | 0.3 % | $ 122 M | USA |
 |
Accuray Incorporated
ARAY
|
160 M | $ 0.5 | -4.78 % | $ 51.4 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.81 | 1.91 % | $ 44.1 M | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 175.78 | -3.51 % | $ 13.2 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 3.7 | -8.31 % | $ 783 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
196 B | $ 110.91 | -1.94 % | $ 193 B | USA |
 |
InMode Ltd.
INMD
|
928 M | $ 13.49 | -0.55 % | $ 872 M | Israel |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 72.61 | 0.55 % | $ 107 B | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.4 | -0.71 % | $ 22.6 M | USA |
 |
IRadimed Corporation
IRMD
|
670 M | $ 100.27 | -4.6 % | $ 1.27 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.26 | -2.16 % | $ 1.37 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.55 | -5.03 % | $ 412 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 83.7 | -1.78 % | $ 48.9 B | USA |
 |
Pulmonx Corporation
LUNG
|
341 M | $ 1.61 | 12.07 % | $ 63 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.53 | 3.41 % | $ 174 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 64.29 | -1.49 % | $ 3.51 B |  Britain |